Related Experiment Videos

Multiple sclerosis and amyloid deposits in the white matter of the brain

I Nennesmo1, N Bogdanovic, A L Petrén

  • 1Division of Pathology, Karolinska Institute, Huddinge Hospital, Sweden. inne@patd01.hs.sll.se

Acta Neuropathologica
|February 1, 1997
PubMed

Insights

Neuropathology revealed multifocal amyloid deposits in the brain white matter of a multiple sclerosis (MS) patient. This finding, unusual in MS, may relate to increased immunoglobulin free light chains.

Area of Science:

  • Neuropathology
  • Neuroimmunology
  • Amyloidosis

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
  • Amyloid deposition is not a typical feature of multiple sclerosis.
  • Previous studies have occasionally reported amyloid in MS, but its significance remains unclear.

Observation:

  • This study details the neuropathological findings in a female patient with a long history of clinically definite multiple sclerosis.
  • The autopsy revealed multifocal amyloid deposits specifically within the white matter of the brain.
  • Crucially, the patient exhibited no other systemic signs of amyloidosis.

Findings:

  • The patient experienced relapsing-remitting MS from age 26 to 45, transitioning to a secondary chronic progressive form for the last 14 years.
  • The presence of amyloid deposits in the brain white matter was a distinct neuropathological finding.
  • No evidence of generalized amyloidosis was observed, localizing the deposits to the central nervous system.

Implications:

  • The findings prompt a re-evaluation of the potential role of amyloid deposits in the pathogenesis of multiple sclerosis.
  • A possible link between these amyloid deposits and the elevated production of immunoglobulin free light chains, often seen in MS, is discussed.
  • Further research is warranted to elucidate the relationship between amyloidosis and immunoglobulin abnormalities in MS progression.

Related Concept Videos